Rexahn Pharmaceuticals IncAdd to My Watchlist

RNN:USNYSEAmericanIndustry: Medical-Biomedical/Gene
  • 2.45
  • 0.01  -0.41%
    Today's Change
  • 2.46
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 9/25/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding28 million
Market Cap$70 million
Return on Equity ttm-151.70%
Last DividendRNN:US does not pay a dividend
EPS: Year Actual ttm-0.934
EPS: Year Est. 12/17 ttm-1.420
EPS: Quarterly Actual 6/17 0.00
EPS: Quarterly Est. 9/17 -0.27
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate50.00
Company Description
Rexahn Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops signal inhibitor therapies for cancer, and treatments for central nervous system diseases.
Net Income$-9 million
Total Assets$21 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!